:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Pancreatic Cancer News
Pancreatic Cancer Breakthrough News

Jan 20, 2008
ASCO GI: Antiangiogenic Agent Shows Promise in Advanced Pancreatic Cancer

  By Charles Bankhead, Staff Writer, MedPage Today

SAN FRANCISCO, Jan. 20 -- Patients with unresectable pancreatic cancer had prolonged survival when a cationic liposomal formulation of paclitaxel was added to gemcitabine (Gemzar), a multinational study showed.    <READ MORE>


Sept 23, 2008
Drug Makers Warn of Liver and Kidney Risks with EGFR-Inhibitor

  By Johns Hopkins Kimmel Cancer Center, (Press Release)

ROCKVILLE, Md., Sept. 23 -- The FDA said today that the makers of the cancer drug erlotinib (Tarceva) have reported two deaths -- one from hepatorenal syndrome and one from rapidly progressing liver failure -- among patients taking the agent.    <READ MORE>


Sept 4, 2008
Comprehensive Blueprints Revealed for Lethal Pancreatic, Brain Cancers

  By Johns Hopkins Kimmel Cancer Center (Press Release)

The complete genetic blueprint for lethal pancreatic cancer and brain cancer was deciphered by a team at the Johns Hopkins Kimmel Cancer Center.   <READ MORE>


July 21, 2008
Node Evaluation for Pancreatic and Gastric Cancer Differentiates Hospitals   

  By Crystal Phend, Staff Writer, MedPage Today

CHICAGO, July 21 -- Better gastric and pancreatic cancer survival rates at high-quality, high-volume cancer centers may be partly because of improved staging through more extensive searches during surgery for metastatic nodes, researchers found.      <READ MORE>


May 20, 2008
Pancreatic Cancer: Advances in Diagnosis and Treatment
Tuesday, May 20 11:00 a.m. ET,10:00 CT, 8:00 PT


On-Demand Video of Live Coverage at
Digestive Disease Week 2008

Medical News from
DDW: Digestive Disease Week Meeting


Apr 25, 2008
ASA: Laparoscopic Surgery Gets Good Grades for Pancreatectomy   

  By Charles Bankhead, Staff Writer, MedPage Today

NEW YORK, April 25 -- For patients with cancer confined to the pancreatic body or tail, laparoscopic left pancreatectomy leads to less morbidity, lower complication rates, and shorter hospitalization, according to data reported here.     <READ MORE>


Apr 17, 2008
AACR: Drug Combo Shows Promise in Advanced Pancreatic Cancer   

  By Charles Bankhead, Staff Writer, MedPage Today

SAN DIEGO, April 17 -- More than 70% of patients with pancreatic cancer derived a clinical benefit when treated in a small, phase I trial with the combination of nanoparticle albumin bound paclitaxel (Abraxane) and gemcitabine (Gemzar), investigators reported here.     <READ MORE>


Mar 4, 2008
Gemcitabine Not a Clear Winner for Adjuvant Treatment of Pancreatic Cancer  

  By Crystal Phend, Staff Writer, MedPage Today

BALTIMORE, March 4 -- Gemcitabine (Gemzar) appears to do little to improve survival for pancreatic cancer patients when added to adjuvant fluorouracil-based chemoradiation after surgery, researchers here found.     <READ MORE>


RNA Patterns May Aid Diagnosis of Pancreatic Cancer (May 01, 2007)

  COLUMBUS, Ohio, May 1 -- To distinguish between pancreatic cancer and pancreatitis, clinicians may soon be able to turn to the expression patterns of short strands of RNA -- so-called microRNAs.  <READ MORE>


:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough Newsletter ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

Copyright ⓒ ICare.  All rights reserved.